PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 82 filers reported holding PLIANT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,564,610 | +62.1% | 436,252 | +69.4% | 0.09% | +61.8% |
| Q2 2023 | $4,665,864 | +53.6% | 257,498 | +43.1% | 0.06% | +10.0% |
| Q3 2021 | $3,038,000 | +45.6% | 179,993 | +151.2% | 0.05% | +28.2% |
| Q2 2021 | $2,087,000 | -39.4% | 71,663 | -52.9% | 0.04% | -65.5% |
| Q3 2020 | $3,443,000 | – | 152,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
| TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
| CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
| GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
| VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
| Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
| Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
| Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
| Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
| First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |